newsfilter
← Latest News
Business Wire·

Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote "FOR" the Transaction With Strongbridge Biopharma

Urges stockholders to vote "FOR" all transaction-related proposals at the Xeris special meeting to be held virtually on September 14, 2021 Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) today announced that a leading independent proxy advisory firm Insti